|4Nov 28, 4:30 PM ET

EASTLAND JULIA MARIE 4

4 · Harpoon Therapeutics, Inc. · Filed Nov 28, 2023

Insider Transaction Report

Form 4
Period: 2023-11-26
Transactions
  • Award

    Common Stock

    2023-11-26+50,00053,503 total
Footnotes (4)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, issuable upon the vesting and settlement of RSUs.
  • [F2]25% of the RSUs will vest on each May 26th and November 26th of 2024 and 2025, subject to acceleration and vesting in full upon a Change in Control (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer, and subject to the continuing employment of the Reporting Person on each vesting date.
  • [F3]Includes 500 shares acquired under the Issuer's employee stock purchase plan on September 30, 2022, 750 shares acquired on March 31, 2023, and 2,253 shares acquired on September 29, 2023.
  • [F4]Shares reflect 1:10 reverse stock split effective September 1, 2023.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24

    POA DOCUMENT